文献速递烧伤创面修复瘢痕与激光

局部类固醇用于抑制烧伤过度肉芽组织:跨大西洋趋势调查

Topical Steroid Use for Suppression of Hypergranulation in Burns: Trends Across the Atlantic.
PubMed 文献 · J Burn Care Res · 2025-01-01

该调查研究了北美和欧洲烧伤协会成员对烧伤后过度肉芽组织使用局部皮质类固醇的现状与认知。165名受访者中,欧洲90人、北美75人,欧洲78.9%常规使用局部类固醇 versus 北美33.3%(P < .001)。欧洲受访者更倾向于认为该疗法安全(100% vs. 74.4%,P < .001)和有效(98.6% vs. 66.7%,P < .001),但两地报告全身副作用无显著差异(6.5% vs. 6.9%,P > .10)。

要点

  • 欧洲受访者78.9%常规使用局部类固醇抑制烧伤过度肉芽组织,北美为33.3%(P < .001)。
  • 欧洲受访者认为局部类固醇安全(100% vs. 74.4%)和有效(98.6% vs. 66.7%)的比例均显著高于北美(P < .001)。
  • 两地报告局部类固醇使用后全身副作用无显著差异(6.5% vs. 6.9%,P > .10)。

核心结论

  • 烧伤过度肉芽组织使用类固醇在欧洲比北美更普遍,可能源于对安全性和有效性的看法不一致,尽管报告的不良反应极少。

研究设计与样本

  • 调查研究,向欧洲烧伤协会和美国烧伤协会成员发放问卷,共165名受访者完成调查(欧洲90人,北美75人),数据采用SPSS软件分析。

主要发现

  • 欧洲受访者90人中有71人(78.9%)报告常规使用局部类固醇抑制烧伤过度肉芽组织,北美受访者75人中有25人(33.3%)报告常规使用(P < .001)。
  • 欧洲受访者认为局部类固醇治疗烧伤过度肉芽创面安全的比例为100%,北美为74.4%(P < .001)。
  • 欧洲受访者认为局部类固醇治疗烧伤过度肉芽创面有效的比例为98.6%,北美为66.7%(P < .001)。
  • 北美受访者报告局部类固醇使用后全身副作用的发生率为6.5%,欧洲受访者为6.9%,两地比较无显著差异(P > .10)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hypergranulated wounds from thermal injury remain a complex and debilitating problem for burn patients. Currently, there is no standard therapy to prevent or treat hypergranulation following burn injury. Many centers use topical corticosteroids; however, their use seems to be geographically dependent and controversial. The primary aim of this study was to quantify the current use of topical corticosteroids for postburn hypergranulation in North America (NA) and Europe, while secondarily assessing for perceptions of safety and efficacy. We designed a survey that was distributed to the members of the European and American Burn Associations. Data were extracted and analyzed using SPSS software. A total of 165 respondents completed the survey (90 and 75 for the European and NA members, respectively). Seventy-one of the 90 (78.9%) European respondents reported they routinely use topical steroids for suppression of hypergranulation tissue in burns, versus 25 of the 75 (33.3%) NA respondents (P < .001). European respondents, compared to NA respondents, were significantly more likely to consider topical steroid use safe (100% vs. 74.4%, P < .001) and effective (98.6% vs. 66.7%, P < .001) for treatment of hypergranulated burn wounds. There was no significant difference in reported systemic effects seen after topical steroid use when comparing NA respondents and European respondents (6.5% vs. 6.9%, P > .10). The results of this study suggest that the use of steroids for hypergranulation tissue in burn care is more prevalent in Europe than NA, which may be due to discordant views on safety and efficacy despite minimal reported adverse effects.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Shoham Y, Comish P, Tsur R, et al. Topical Steroid Use for Suppression of Hypergranulation in Burns: Trends Across the Atlantic. J Burn Care Res. 2025. PMID: 39475084. doi:10.1093/jbcr/irae191

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。